A stroke is a medical emergency, capable of damaging the brain through interruption of its blood supply. There are many symptoms of stroke including difficulties walking, speaking, and understanding, as well as numbness of the face, arm, or leg. When it comes to treating subacute stroke in an inpatient rehabilitation setting, Dr. Crissy Voigtmann (Doctor of Physical Therapy and board-certified Neurological Clinical Specialist), Dr. CJ Curran (Doctor of Physical Therapy, certified brain injury specialist and board-certified Neurological Clinical Specialist), and Jose Dominguez (Director of Rehabilitation, Orlando Health) give professional insight on EksoNR, the first FDA-cleared exoskeleton for stroke and spinal cord injury, and the only FDA-cleared exoskeleton for acquired brain injury.

Orlando Health ORMC Institute for Advanced Rehabilitation (IAR) is a CARF accredited inpatient and outpatient rehab unit partnered with Ekso Bionics since 2019. Currently, they have four Level-Two trained therapists at the inpatient rehabilitation, and two Level-Two trained therapists at their outpatient rehabilitation.

What is EksoNR?

Currently, EksoNR is the only exoskeleton that is FDA-cleared for acquired brain injury. It is the first FDA-cleared exoskeleton and extremely adaptive with short-term implications as well as long-term ones. The device is capable of progressing through programming as a stroke patient progresses in recovery. This gives the long-term capability to adapt from session to session, not only for patients with strokes but spinal cord injuries or TBI.